Group 1 - The event marked a new phase of deep integration between Shaanxi and Hong Kong, transitioning from economic and trade exchanges to capital market collaboration [1] - Over 70 representatives from government, financial institutions, and enterprises participated in the event, highlighting the importance of cross-border financial services [1] - Six key enterprises from Shaanxi showcased their innovations in sectors such as financial asset management, new energy vehicles, biotechnology, high-end medical equipment, smart electricity, artificial intelligence, and 3D visual technology [1] Group 2 - The demand for cross-border finance and professional services from Shaanxi enterprises has been increasing as their internationalization accelerates [2] - The event aimed to facilitate a seamless process for Shaanxi enterprises to achieve "listing—financing—development" in Hong Kong, providing a fast track to international capital markets [2] - The collaboration is expected to explore new models and expand opportunities in areas such as industrial investment, technological cooperation, green finance, and professional services [2]

Group 1 - The Hang Seng Innovation Drug Index and the Hang Seng Hong Kong Stock Connect Innovation Drug Index have undergone a composition adjustment effective from August 11 [1] - The new calculation method excludes companies primarily engaged in the CXO industry, including Contract Research Organizations (CRO), Contract Manufacturing Organizations (CMO), and Contract Development and Manufacturing Organizations (CDMO) [1] - The adjustment introduces a requirement for Southbound trading connectivity, meaning only stocks that meet the Hong Kong Stock Connect criteria can be included, enhancing investment convenience [1] Group 2 - The Hang Seng Innovation Drug Index will maintain a fixed number of 40 constituent stocks, with eligible securities selected based on their relevance to innovative drug business [1] - The adjustment reflects the latest development trends in the Hong Kong innovative drug sector, providing investors with a more precise market benchmark [1] - The changes also indicate a trend of deeper integration between the capital markets of the two regions as the connectivity mechanism continues to improve [1]